Literature DB >> 19910012

Occult lymph node metastases in neck level V in papillary thyroid carcinoma.

Young Chang Lim1, Eun Chang Choi, Yeo-Hoon Yoon, Bon Seok Koo.   

Abstract

BACKGROUND: The extent of lateral neck dissection for clinically evident nodal metastases in the lateral neck in a patient with papillary thyroid cancer (PTC) continues to remain controversial.
METHODS: We reviewed retrospectively the medical records between March 2005 and March 2008 of 70 patients with PTC who underwent therapeutic lateral neck dissections (level II-V) to establish indications for omission of a level V lymphadenectomy. No patient in the study had a clinically positive level V lymph node. Neck dissection specimens were obtained for histologic analysis for node metastasis with respect to the individual neck levels.
RESULTS: Thirty-four (49%), 52 (74%), and 48 (69%) patients had histologically positive lymph nodes in levels II, III, and IV, respectively. Occult metastases in level V were observed in 11 (16%) patients. Isolated positive level V lymph nodes were never found, while all patients with positive level V lymph nodes had simultaneous positive level IV lymph nodes. In addition, there was no instance of a pathologically positive lymph node in level V without a suspicious metastatic lymph node in level IV by preoperative ultrasonography. In multivariate analysis, simultaneous multilevel involvement (level II, III, and IV) of lymphatic metastases was associated with level V metastasis.
CONCLUSION: Level V lymphadenectomy may be omitted in the treatment of PTC patients if positive nodes are not found on histologic exam (frozen section analysis) or by ultrasonography in level IV. Copyright 2010 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 19910012     DOI: 10.1016/j.surg.2009.09.002

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  11 in total

Review 1.  Individualized optimal surgical extent of the lateral neck in papillary thyroid cancer with lateral cervical metastasis.

Authors:  Jae-Yong Park; Bon Seok Koo
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-07-16       Impact factor: 2.503

2.  Candidates for limited lateral neck dissection among patients with metastatic papillary thyroid carcinoma.

Authors:  Byung Chul Kang; Jong-Lyel Roh; Jeong Hyun Lee; Kyung-Ja Cho; Gyungyub Gong; Seung-Ho Choi; Soon Yuhl Nam; Sang Yoon Kim
Journal:  World J Surg       Date:  2014-04       Impact factor: 3.352

Review 3.  German Association of Endocrine Surgeons practice guideline for the surgical management of malignant thyroid tumors.

Authors:  Henning Dralle; Thomas J Musholt; Jochen Schabram; Thomas Steinmüller; Andreja Frilling; Dietmar Simon; Peter E Goretzki; Bruno Niederle; Christian Scheuba; Thomas Clerici; Michael Hermann; Jochen Kußmann; Kerstin Lorenz; Christoph Nies; Peter Schabram; Arnold Trupka; Andreas Zielke; Wolfram Karges; Markus Luster; Kurt W Schmid; Dirk Vordermark; Hans-Joachim Schmoll; Reinhard Mühlenberg; Otmar Schober; Harald Rimmele; Andreas Machens
Journal:  Langenbecks Arch Surg       Date:  2013-03-03       Impact factor: 3.445

4.  Efficacy of Superselective Neck Dissection in Detecting Metastasis in Patients with cN0 Papillary Thyroid Carcinoma at High Risk of Lateral Neck Metastasis.

Authors:  Changming An; Xiwei Zhang; Shixu Wang; Zongmin Zhang; Yulin Yin; Zhengang Xu; Pingzhang Tang; Zhengjiang Li
Journal:  Med Sci Monit       Date:  2017-05-04

5.  Predictive Factors for Level V Lymph Node Metastases in Papillary Thyroid Carcinoma with BRAFV600E Mutation and Clinicopathological Features.

Authors:  Gui-You Li; Hai-Long Tan; Pei Chen; Hui-Yu Hu; Mian Liu; Deng-Jie Ou-Yang; Rooh-Afza Khushbu; Deepak Pun; Jin-Dong Li; Zhi-Peng Zhang; Qiong Yang; Peng Huang; Shi Chang
Journal:  Cancer Manag Res       Date:  2020-05-13       Impact factor: 3.989

6.  Optimal surgical extent of lateral and central neck dissection for papillary thyroid carcinoma located in one lobe with clinical lateral lymph node metastasis.

Authors:  Hyo Sub Keum; Yong Bae Ji; Jong Min Kim; Jin Hyeok Jeong; Woong Hwan Choi; You Hern Ahn; Kyung Tae
Journal:  World J Surg Oncol       Date:  2012-10-25       Impact factor: 2.754

7.  Should level V be included in lateral neck dissection in treating papillary thyroid carcinoma?

Authors:  Xiao-Jun Zhang; Dan Liu; De-Bin Xu; Ya-Qi Mu; Wen-Kuan Chen
Journal:  World J Surg Oncol       Date:  2013-11-25       Impact factor: 2.754

8.  Risk factors for level V lymph node metastases in solitary papillary thyroid carcinoma with clinically lateral lymph node metastases.

Authors:  Jing Yang; Yanping Gong; Shuping Yan; Jingqiang Zhu; Zhihui Li; Rixiang Gong
Journal:  Cancer Med       Date:  2016-07-01       Impact factor: 4.452

Review 9.  Level V Clearance in Neck Dissection for Papillary Thyroid Carcinoma: A Need for Homogeneous Studies.

Authors:  Azhar Jan Battoo; Zahoor Ahmad Sheikh; Krishnakumar Thankappan; Abdul Wahid Mir; Altaf Gowhar Haji
Journal:  Int Arch Otorhinolaryngol       Date:  2017-12-13

10.  Pattern of and clinicopathologic risk factors for lateral lymph node metastases in papillary thyroid carcinoma patients with lateral cervical lymphadenopathy.

Authors:  Yanping Gong; Jing Yang; Shuping Yan; Anping Su; Feng Liu; Rixiang Gong; Jingqiang Zhu; Zhihui Li
Journal:  Medicine (Baltimore)       Date:  2018-09       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.